News Focus
News Focus
Followers 3414
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: jas2mel post# 26954

Sunday, 04/25/2010 11:52:31 PM

Sunday, April 25, 2010 11:52:31 PM

Post# of 97241
POZN ($10.86)…Vimovo is a featured product for Astra Zeneca in their 2009 Shareholder Meeting. POZN is not alone in wanting this product to be approved! A lot on the line here and POZN has a key partner in the U.S. and internationally.


Sheff's Station...All Aboard...Sign Up Here!

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today